Diese Veranstaltung hat bereits stattgefunden

Web-Seminar

Sa29 Current concepts in the management of submacular hemorrhage in AMD

Symposium of the DOG 2020 Online
online, Deutschland
Veranstaltungsnummer: 34206
Zertifizierung: beantragt
Gebühren ab: gebührenfrei
verfügbare Plätze: unbegrenzt
Sprache: Deutsch

 Zum Kalender hinzufügen
  • Datum
    10.10.2020, 18:30 - 19:15
    Veranstalter
    DOG - Deutsche Ophthalmologische Gesellschaft e.V.
    Kurzbeschreibung
    The symposium will summarise what is known about SMH in AMD and discuss a variety of therapeutic interventions including practical skills, techniques, and open questions. Main topics include: established clinical classification of SMH further developed by fundus imaging, Epidemiology, risk factors, and the effect of anti-VEGF monotherapy and many more.
    Gebühren

    Fachärzte

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    120,00 €
    Hinweis
    This symposium is part of the DOG congress 2020 (9.-11.2020). The attandance for the total congress costs 250€ for members and 120€ for non-members.

    Ärzte/-innen in Weiterbildung

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    120,00 €
    Hinweis
    This symposium is part of the DOG congress 2020 (9.-11.2020). The attandance for the total congress costs 250€ for members and 120€ for non-members.

    Studenten/-innen

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    kostenlos
    Hinweis
    The full congress is free for students and PhD students.
  •  

    18:30 – 18:36

    Sa29-01 - A revised classification of submacular haemorrhage using ocular imaging is helpful in clinical decision making

    Referent/in: Silvia Bopp, Bremen

    18:36 – 18:42

    Sa29-02 - Epidemiology and risk factors of submacular hemorrhage in AMD and anti-VEGF monotherapy

    Referent/in: Nicolas Feltgen, Göttingen

    The epidemiological data of submacular hemorrhage are presented, additionally the spontaneous course and efficacy of anti-VEGF monotherapy.

    18:42 – 18:48

    Sa29-03 - Reducing risks in the management of macular hemorrhage - minimally invasive and digitally assisted surgical approaches

    Referent/in: Lars-Olof Hattenbach, Ludwigshafen

    18:48 – 18:54

    Sa29-04 - Autologous RPE-choroid patch translocation for large submacular hemorrhages in AMD: evolution of an established surgical technique

    Referent/in: Grazia Pertile, Verona, Italy

    18:54 – 19:00

    Sa29-05 - TIGER: a pan-European randomized clinical trial investigating treatment of submacular hemorrhage in AMD

    Referent/in: Jost Hillenkamp, Würzburg

    The TIGER study is a 65 centre non-commercial pan-European randomized clinical trial funded by Euretina and supported by Bayer investigating treatment of submacular hemorrhage in AMD. The aim is to study safety and efficacy of vitrectomy, sub-retinal TPA and gas for submacular haemorrhage due to wet AMD followed by intravitreal application of aflibercept compared to treatment with intravitreal aflibercept alone.

    19:00 – 19:15

    Sa29-06 - Diskussion

  • This symposium is virtual. Saal von Graefe

    INTERPLAN AG
    Congress, Meeting & Event Management AG
    Landsberger Straße 155
    DE - 80687 München
    Tel.: +49 (0)89 548 234 35
    Tel.: +49 (0)89 548 234 0
    Fax: +49 (0)89 548 234 43
    Fax: +49 (0)89 548 234 44

    Chairman

    Jost Hillenkamp, Würzburg
    Lars-Olof Hattenbach, Ludwigshafen
  • Please contact the roganizer for further information.